RTTNews | Oct 1, 2021 12:06PM EDT

12:06 Friday, October 1, 2021 (RTTNews.com) - Shares of Atea Pharmaceuticals, Inc. (AVIR) are gaining over 15% on Friday morning despite no stock related news to drive the shares.

AVIR is currently trading at $40.62, up $5.56 or 15.86%, on the Nasdaq, on a volume of 8.2 million shares, above average volume of 1.3 million shares. The stock has traded between $18.72 and $94.17 in the 52 week period.

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, a novel antiviral agent that is in Phase II clinical trial for the treatment of patients with COVID-19.

Read the original article on RTTNews ( https://www.rttnews.com/3229949/atea-pharmaceuticals-stock-gains-15.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved